CPT vs TERN · P/E 104, rev $7.1M vs $6.12B cap
Camden Property Trust (CPT) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Camden Property Trust (CPT) is a reit - residential company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported CPT revenue for 2024-12-31 was $7.1M. Net income was $170.8M. Revenue was up 106.8% from 2023-12-31 to 2024-12-31. CPT currently screens at market cap $12.11B and trailing P/E 104.0.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
CPT currently screens at market cap $12.11B and trailing P/E 104.0. TERN currently screens at market cap $6.12B.
Not investment advice. Open the CPT and TERN stock pages for the full models.
Not investment advice.